Literature DB >> 28105278

Hydrazone Linker as a Useful Tool for Preparing Chimeric Peptide/Nonpeptide Bifunctional Compounds.

Jolanta Dyniewicz1, Piotr F J Lipiński1, Piotr Kosson1, Anna Leśniak1, Marta Bochyńska-Czyż1, Adriana Muchowska1, Dirk Tourwé2, Steven Ballet2, Aleksandra Misicka1, Andrzej W Lipkowski1.   

Abstract

The area of multitarget compounds, joining two pharmacophores within one molecule, is a vivid field of research in medicinal chemistry. Not only pharmacophoric elements are essential for the design and activity of such compounds, but the type and length of linkers used to connect them are also crucial. In the present contribution, we describe compound 1 in which a typical opioid peptide sequence is combined with a fragment characteristic for neurokinin-1 receptor (NK1R) antagonists through a hydrazone bridge. The compound has a high affinity for μ- and δ-opioid receptors (IC50= 12.7 and 74.0 nM, respectively) and a weak affinity for the NK1R. Molecular modeling and structural considerations explain the observed activities. In in vivo test, intrathecal and intravenous administrations of 1 exhibited a strong analgesic effect, which indicates potential BBB penetration. This letter brings an exemplary application of the hydrazone linker for fast, facile, and successful preparation of chimeric compounds.

Entities:  

Keywords:  Bifunctional ligands; NK1 antagonists; hydrazone linker; opioid agonists

Year:  2016        PMID: 28105278      PMCID: PMC5238479          DOI: 10.1021/acsmedchemlett.6b00381

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  29 in total

1.  Spinal antinociceptive effects of AA501, a novel chimeric peptide with opioid receptor agonist and tachykinin receptor antagonist moieties.

Authors:  Iwona Maszczynska Bonney; Stacy E Foran; James E Marchand; Andrzej W Lipkowski; Daniel B Carr
Journal:  Eur J Pharmacol       Date:  2004-03-19       Impact factor: 4.432

Review 2.  The design of multitarget ligands for chronic and neuropathic pain.

Authors:  Szabolcs Dvoracsko; Azzurra Stefanucci; Ettore Novellino; Adriano Mollica
Journal:  Future Med Chem       Date:  2015-12-11       Impact factor: 3.808

3.  Synthesis and biological evaluation of new biphalin analogues with non-hydrazine linkers.

Authors:  Adriano Mollica; Peg Davis; Shou-Wu Ma; Josephine Lai; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2005-05-16       Impact factor: 2.823

4.  Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist.

Authors:  Steven Ballet; Debby Feytens; Koen Buysse; Nga N Chung; Carole Lemieux; Suneeta Tumati; Attila Keresztes; Joost Van Duppen; Josephine Lai; Eva Varga; Frank Porreca; Peter W Schiller; Jozef Vanden Broeck; Dirk Tourwé
Journal:  J Med Chem       Date:  2011-03-17       Impact factor: 7.446

5.  Effects of novel acylhydrazones derived from 4-quinolone on the acetylcholinesterase activity and Aβ42 peptide fibrils formation.

Authors:  Gisele S da Silva; Micheli Figueiró; Claudio F Tormena; Fernando Coelho; Wanda P Almeida
Journal:  J Enzyme Inhib Med Chem       Date:  2016-03-01       Impact factor: 5.051

6.  Dimeric tetrapeptide enkephalins display extraordinary selectivity for the delta opiate receptor.

Authors:  Y Shimohigashi; T Costa; H C Chen; D Rodbard
Journal:  Nature       Date:  1982-05-27       Impact factor: 49.962

7.  Derivation of a three-dimensional pharmacophore model of substance P antagonists bound to the neurokinin-1 receptor.

Authors:  Y Takeuchi; E F Shands; D D Beusen; G R Marshall
Journal:  J Med Chem       Date:  1998-09-10       Impact factor: 7.446

8.  Antinociception after intrathecal biphalin application in rats: a reevaluation and novel, rapid method to confirm correct catheter tip position.

Authors:  Dariusz Kosson; Iwona Bonney; Daniel B Carr; Ewa Mayzner-Zawadzka; Andrzej W Lipkowski
Journal:  Pharmacol Rep       Date:  2005 Jul-Aug       Impact factor: 3.024

9.  Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity.

Authors:  G Y Ng; J Clark; N Coulombe; N Ethier; T E Hebert; R Sullivan; S Kargman; A Chateauneuf; N Tsukamoto; T McDonald; P Whiting; E Mezey; M P Johnson; Q Liu; L F Kolakowski; J F Evans; T I Bonner; G P O'Neill
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

10.  Structural basis for bifunctional peptide recognition at human δ-opioid receptor.

Authors:  Gustavo Fenalti; Nadia A Zatsepin; Cecilia Betti; Patrick Giguere; Gye Won Han; Andrii Ishchenko; Wei Liu; Karel Guillemyn; Haitao Zhang; Daniel James; Dingjie Wang; Uwe Weierstall; John C H Spence; Sébastien Boutet; Marc Messerschmidt; Garth J Williams; Cornelius Gati; Oleksandr M Yefanov; Thomas A White; Dominik Oberthuer; Markus Metz; Chun Hong Yoon; Anton Barty; Henry N Chapman; Shibom Basu; Jesse Coe; Chelsie E Conrad; Raimund Fromme; Petra Fromme; Dirk Tourwé; Peter W Schiller; Bryan L Roth; Steven Ballet; Vsevolod Katritch; Raymond C Stevens; Vadim Cherezov
Journal:  Nat Struct Mol Biol       Date:  2015-02-16       Impact factor: 15.369

View more
  5 in total

Review 1.  Biphalin-A Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases?

Authors:  Patrycja Redkiewicz; Jolanta Dyniewicz; Aleksandra Misicka
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

2.  Novel NK1R-Targeted 68Ga-/177Lu-Radioconjugates with Potential Application against Glioblastoma Multiforme: Preliminary Exploration of Structure-Activity Relationships.

Authors:  Joanna Matalińska; Katarzyna Kosińska; Paweł K Halik; Przemysław Koźmiński; Piotr F J Lipiński; Ewa Gniazdowska; Aleksandra Misicka
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

3.  Catalyst- and Additive-Free C(sp3)-H Functionalization of (Thio)barbituric Acids via C-5 Dehydrogenative Aza-Coupling Under Ambient Conditions.

Authors:  Goutam Brahmachari; Anindita Bhowmick; Indrajit Karmakar
Journal:  ACS Omega       Date:  2022-08-17

Review 4.  Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery.

Authors:  Yeon Sun Lee
Journal:  Biomolecules       Date:  2022-09-05

5.  Antinociceptive and Cytotoxic Activity of Opioid Peptides with Hydrazone and Hydrazide Moieties at the C-Terminus.

Authors:  Jolanta Dyniewicz; Piotr F J Lipiński; Piotr Kosson; Marta Bochyńska-Czyż; Joanna Matalińska; Aleksandra Misicka
Journal:  Molecules       Date:  2020-07-28       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.